Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2003
03/20/2003US20030054379 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer, immunological, viral and autoimmune disease
03/20/2003US20030054377 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer, cardovascular and nervous system disorders
03/20/2003US20030054375 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of connective tissue and cancer disorders
03/20/2003US20030054373 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
03/20/2003US20030054368 Nucleic acids, proteins and antibodies
03/20/2003US20030054365 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression
03/20/2003US20030054359 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
03/20/2003US20030054352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054351 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054349 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054341 Viral nucleotide sequences for use in diagnosis, prevention and treatment of viral diseases
03/20/2003US20030054335 Cell culturing method and device
03/20/2003US20030054333 Biosensor for use as diagnostic tool in monitoring cell metabolism
03/20/2003US20030054331 Recovering and preserving stem cells; obtain adipose tissue, educt, filter, separate and freeze tissue recovered
03/20/2003US20030054054 Antitumor agent
03/20/2003US20030054052 Triterpene compositions and methods for use thereof
03/20/2003US20030054035 Biodegradation membrane
03/20/2003US20030054013 Tuberculosis therapy; anticancer agents
03/20/2003US20030054003 Antitumor agents, anticarcinogenic agents
03/20/2003US20030053997 Expansion in situ; cognition activators
03/20/2003US20030053996 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/20/2003US20030053993 Regeneration of nerve cells
03/20/2003US20030053992 Embryonic stem cells, clinical applications and methods for expanding in vitro
03/20/2003US20030053991 Retinoic acid receptor beta-2, its agonists, and gene theraphy vectors for the treatment of neurological disorders
03/20/2003US20030053990 Virus vectors and methods of making and administering the same
03/20/2003US20030053988 Genetic engineering; culture product; process control
03/20/2003US20030053984 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins
03/20/2003CA2497954A1 Pancreatic small cells and uses thereof
03/20/2003CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003CA2460269A1 Alphavirus replicon vector systems
03/20/2003CA2460092A1 A method of diagnosis and treatment and agents useful for same
03/20/2003CA2459806A1 Method for increasing stress tolerance in plants
03/20/2003CA2459713A1 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
03/20/2003CA2459560A1 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003CA2459426A1 Human immunodeficiency virus envelope glycoprotein mutants and uses thereof
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003CA2459280A1 Device and method to maintain vascularization near implant
03/20/2003CA2459202A1 Adipose-derived stem cells and lattices
03/20/2003CA2458543A1 Compositions and methods for treatment of cancer
03/20/2003CA2457287A1 Production and use of human cd124 and cd116 positive tumour cell lines in the production of allogenic or semi-allogenic immunotherapy agents
03/20/2003CA2456561A1 Multiplication of viruses in a cell culture
03/20/2003CA2455990A1 Methods for diagnosing and treating diseases and conditions associated with protein kinase c.lambda.
03/20/2003CA2454992A1 Adenoviral vector and related system and methods of making and use
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2451254A1 Novel proteins and nucleic acids encoding same
03/19/2003EP1293566A1 A soluble toll-like receptor
03/19/2003EP1293565A2 Mammalian telomerase RNA component
03/19/2003EP1293562A1 Fungal glyoxal oxidases
03/19/2003EP1293561A1 Monkey-origin embryonic stem cells
03/19/2003EP1293514A1 Multimeric single chain tandem Fv-antibodies
03/19/2003EP1293513A2 A recombinant human factor VIII derivative
03/19/2003EP1293512A2 DNA encoding the baboon and cynomolgus macaque prostaglandin E2 receptor EP4 subtype
03/19/2003EP1293212A1 Anti cancer vaccine comprising whole cancer cells with modified sialic acid
03/19/2003EP1292827A1 T2r taste receptors and genes encoding same
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292693A2 Grain processing method and transgenic plants useful therein
03/19/2003EP1292688A2 Promoters for regulated gene expression
03/19/2003EP1292685A2 Human lyases
03/19/2003EP1292684A2 Proteases
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292681A1 Antigenic polypeptides
03/19/2003EP1292680A2 Agonist anti-trk-c monoclonal antibodies
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292676A1 Mutation associated with epilepsy
03/19/2003EP1292674A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
03/19/2003EP1292671A1 Method for obtaining characterised muscle-derived cell populations and uses
03/19/2003EP1292670A2 Cost effective media for large scale insect cell culture
03/19/2003EP1292668A2 Gene disruption methodologies in fungi for drug target discovery
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292617A1 Novel compounds
03/19/2003EP1292616A2 Nucleic acids encoding a regulator of g protein signaling, rgs18, and uses thereof
03/19/2003EP1292321A1 Method to increase class i presentation of exogenous antigens by human dendritic cells
03/19/2003EP1292249A1 Tissue engineered stents
03/19/2003EP1292186A1 Animal and cell models for type ii diabetes and their use
03/19/2003EP1034268A4 G-protein coupled receptors and uses therefor
03/19/2003EP0964697B1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
03/19/2003EP0910409A4 Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0722463B1 Methods and composition for the modulation of host immune response to allergens
03/19/2003EP0677104B1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use
03/19/2003EP0667902B1 Cdr grafted humanised chimeric t-cell antibodies
03/19/2003EP0595935B1 Papillomavirus Vaccine
03/19/2003EP0556333B1 Avirulent salmonella microbes comprising a mutation in the cdt gene and uses therefor
03/19/2003CN1404528A Transgenic cells expressing glucosyltransferase nucleic acids
03/19/2003CN1404526A Method of making embryoid bodies from primate embryonic stem cells
03/19/2003CN1404488A NOGO receptor-mediated blockade of axonal growth
03/19/2003CN1404401A G-CSF conjugates
03/19/2003CN1403572A Plant cell engineering process of producing puerarin
03/19/2003CN1403571A Ephedra crown-gall nodule cell ZHA-2 CGMCC NO.0521 and its inducing method
03/19/2003CN1103372C Process for producing cell containing resveratrol
03/19/2003CN1103371C Humi grass cell engineering seedling large scale breeding technology
03/18/2003US6534644 Isolated polynucleotide of given sequence; use to control lepidopterans and create plants that are insect resistant
03/18/2003US6534643 Isolated nucleic acid of given sequence; useful for homology-dependent pairing of three DNA strands; use in cloning and gene mapping
03/18/2003US6534641 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease.
03/18/2003US6534632 Sialidase localized in plasma membrane DNA coding for the same
03/18/2003US6534630 Connective tissue growth factor-2
03/18/2003US6534538 A non-murine heart valve cell containing an exogenous nucleic acid that encodes a polypeptide having nitric oxide synthase activity; slows heart valve degeneration, thrombosis, and calcification, treats carcinoid heart disease
03/18/2003US6534485 Novel human protein called Bone Marrow-Specific Protein (BMSP), and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein.
1 ... 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 ... 1827